Literature DB >> 24011515

Cyclodextrin derivatives as anti-infectives.

Vladimir A Karginov1.   

Abstract

Cyclodextrin derivatives can be utilized as anti-infectives with pore-forming proteins as the targets. The highly efficient selection of potent inhibitors was achieved because per-substituted cyclodextrins have the same symmetry as the target pores. Inhibitors of several bacterial toxins produced by Bacillus anthracis, Staphylococcus aureus, Clostridium perfringens, Clostridium botulinum, and Clostridium difficile were identified from a library of ∼200 CD derivatives. It was demonstrated that multi-targeted inhibitors can be found using this approach and could be utilized for the development of broad-spectrum drugs against various pathogens.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24011515      PMCID: PMC3823528          DOI: 10.1016/j.coph.2013.08.007

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  51 in total

1.  Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model.

Authors:  Adam D Kennedy; Juliane Bubeck Wardenburg; Donald J Gardner; Daniel Long; Adeline R Whitney; Kevin R Braughton; Olaf Schneewind; Frank R DeLeo
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

2.  Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design.

Authors:  Vladimir A Karginov; Ekaterina M Nestorovich; Mahtab Moayeri; Stephen H Leppla; Sergey M Bezrukov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-07       Impact factor: 11.205

3.  Search for cyclodextrin-based inhibitors of anthrax toxins: synthesis, structural features, and relative activities.

Authors:  Vladimir A Karginov; Ekaterina M Nestorovich; Adiamseged Yohannes; Tanisha M Robinson; Nour Eddine Fahmi; Frank Schmidtmann; Sidney M Hecht; Sergey M Bezrukov
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

4.  Structure-based design of a heptavalent anthrax toxin inhibitor.

Authors:  Amit Joshi; Sandesh Kate; Vincent Poon; Dhananjoy Mondal; Mohan B Boggara; Arundhati Saraph; Jacob T Martin; Ryan McAlpine; Ryan Day; Angel E Garcia; Jeremy Mogridge; Ravi S Kane
Journal:  Biomacromolecules       Date:  2011-02-08       Impact factor: 6.988

5.  Inhibition of S. aureus alpha-hemolysin and B. anthracis lethal toxin by beta-cyclodextrin derivatives.

Authors:  Vladimir A Karginov; Ekaterina M Nestorovich; Frank Schmidtmann; Tanisha M Robinson; Adiamseged Yohannes; Nour Eddine Fahmi; Sergey M Bezrukov; Sidney M Hecht
Journal:  Bioorg Med Chem       Date:  2007-05-26       Impact factor: 3.641

6.  Inhibition of anthrax protective antigen outside and inside the cell.

Authors:  Marina V Backer; Vimal Patel; Brian T Jehning; Kevin P Claffey; Vladimir A Karginov; Joseph M Backer
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

7.  The protective antigen component of anthrax toxin forms functional octameric complexes.

Authors:  Alexander F Kintzer; Katie L Thoren; Harry J Sterling; Ken C Dong; Geoffrey K Feld; Iok I Tang; Teri T Zhang; Evan R Williams; James M Berger; Bryan A Krantz
Journal:  J Mol Biol       Date:  2009-07-20       Impact factor: 5.469

8.  Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement.

Authors:  A H Patel; P Nowlan; E D Weavers; T Foster
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

Review 9.  Anti-toxin antibodies in prophylaxis and treatment of inhalation anthrax.

Authors:  Anette Schneemann; Marianne Manchester
Journal:  Future Microbiol       Date:  2009-02       Impact factor: 3.165

10.  The molecular basis of the specific anti-influenza action of amantadine.

Authors:  A J Hay; A J Wolstenholme; J J Skehel; M H Smith
Journal:  EMBO J       Date:  1985-11       Impact factor: 11.598

View more
  12 in total

Review 1.  Inhibiting bacterial toxins by channel blockage.

Authors:  Sergey M Bezrukov; Ekaterina M Nestorovich
Journal:  Pathog Dis       Date:  2015-12-09       Impact factor: 3.166

2.  A monodisperse transmembrane α-helical peptide barrel.

Authors:  Kozhinjampara R Mahendran; Ai Niitsu; Lingbing Kong; Andrew R Thomson; Richard B Sessions; Derek N Woolfson; Hagan Bayley
Journal:  Nat Chem       Date:  2016-11-14       Impact factor: 24.427

3.  Inhibition of Clostridium perfringens epsilon toxin by β-cyclodextrin derivatives.

Authors:  Tanisha M Robinson; Laszlo Jicsinszky; Andrei V Karginov; Vladimir A Karginov
Journal:  Int J Pharm       Date:  2017-07-25       Impact factor: 5.875

Review 4.  Designing inhibitors of anthrax toxin.

Authors:  Ekaterina M Nestorovich; Sergey M Bezrukov
Journal:  Expert Opin Drug Discov       Date:  2014-01-22       Impact factor: 6.098

Review 5.  An overview of investigational toxin-directed therapies for the adjunctive management of Bacillus anthracis infection and sepsis.

Authors:  Lernik Ohanjanian; Kenneth E Remy; Yan Li; Xizhong Cui; Peter Q Eichacker
Journal:  Expert Opin Investig Drugs       Date:  2015-04-28       Impact factor: 6.206

Review 6.  Channel-forming bacterial toxins in biosensing and macromolecule delivery.

Authors:  Philip A Gurnev; Ekaterina M Nestorovich
Journal:  Toxins (Basel)       Date:  2014-08-21       Impact factor: 4.546

Review 7.  Pathoblockers or antivirulence drugs as a new option for the treatment of bacterial infections.

Authors:  Matthew B Calvert; Varsha R Jumde; Alexander Titz
Journal:  Beilstein J Org Chem       Date:  2018-10-11       Impact factor: 2.883

8.  Cyclodextrins as multifunctional excipients: Influence of inclusion into β-cyclodextrin on physicochemical and biological properties of tebipenem pivoxil.

Authors:  Magdalena Paczkowska; Daria Szymanowska-Powałowska; Mikołaj Mizera; Dominika Siąkowska; Wioletta Błaszczak; Hanna Piotrowska-Kempisty; Judyta Cielecka-Piontek
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

9.  Hydroxypropyl-β-cyclodextrin as an effective carrier of curcumin - piperine nutraceutical system with improved enzyme inhibition properties.

Authors:  Anna Stasiłowicz; Ewa Tykarska; Kornelia Lewandowska; Maciej Kozak; Andrzej Miklaszewski; Joanna Kobus-Cisowska; Daria Szymanowska; Tomasz Plech; Jacek Jenczyk; Judyta Cielecka-Piontek
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

10.  Design, Synthesis and Evaluation of Novel Antimicrobial Polymers Based on the Inclusion of Polyethylene Glycol/TiO2 Nanocomposites in Cyclodextrin as Drug Carriers for Sulfaguanidine.

Authors:  Hemat M Dardeer; Arafat Toghan; Magdi E A Zaki; Rokaia B Elamary
Journal:  Polymers (Basel)       Date:  2022-01-06       Impact factor: 4.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.